Mansukh Mandaviya Meeting With Pharma Company Mandatory RTPCR Test China Hong Kong South Korea Japan Singapore Thailand ANN | COVID 19: Corona negative report is necessary for passengers coming from 6 countries including China, health minister gave these instructions to pharmaceutical companies

Mansukh Mandaviya Meeting With Pharma Company Mandatory RTPCR Test China Hong Kong South Korea Japan Singapore Thailand ANN |  COVID 19: Corona negative report is necessary for passengers coming from 6 countries including China, health minister gave these instructions to pharmaceutical companies


Coronavirus In India: In the midst of increasing corona in many countries including China, America and Japan, the Government of India is also making different preparations. The Union Health Ministry is holding meetings every day. Along with this, the state government is also making many types of rules. This is happening so that Kovid-19 does not increase in the country. Let’s know 10 big things.

Ten big things

1- The Government of India has made RT-PCR test mandatory for passengers coming from China, Hong Kong, Japan, South Korea, Singapore and Thailand from January 1, 2023. People coming before these countries will have to upload their negative reports on the Air Suvidha portal. This test should be done within 72 hours of traveling to India. Union Health Minister Mansukh Mandaviya informed about this by tweeting.

2- Random testing of 2 percent of all passengers coming to India is being done. For this, the Union Health Ministry has already issued guidelines. This is being followed at all airports.

3- Health Minister Mansukh Mandaviya held a meeting with representatives of pharma companies through video conferencing on Thursday (December 29). In this, he discussed the stock of medicines used in corona clinical management and treatment and gave some guidelines.

4-Union Health Minister Mansukh Mandaviya has asked pharma companies to keep a close watch on the global supply chain scenario. Along with this, along with the production and availability of API, attention has been asked to pay attention to the minuteness of manufacturing of medicines required for Kovid management.

5- Union Health Minister Mansukh Mandaviya has asked pharma companies to ensure adequate stock and availability of all medicines including COVID-19 drugs in the supply chain till the retail level.

6- Apart from Union Health Minister Mansukh Mandaviya, Union Health Secretary Rajesh Bhushan, Pharma Secretary Sushri S Aparna, NPPA President Kamlesh Pant, Drug Controller General of India Dr VG Somani and representatives of pharmaceutical companies were present in the review meeting.

7- Cases of corona infection are increasing rapidly in China, Hong Kong, Japan, South Korea, Singapore and Thailand. The sub-variant BF.7 (BF.7) of the Omicron variant of Corona is responsible for most of the Covid cases in these countries.

8- Government sources say that in the next 40 days there may be a boom in the case of corona in India. In view of this, the Union Health Ministry is on alert and has stepped up the preparations.

9- Five cases of the BF.7 variant, a sub-variant of the Omicron variant, have been reported in the country since July. They have come from Gujarat and Odisha. All five patients had mild symptoms.

10- According to the data released on Thursday (December 29) by the Union Ministry of Health, in India, corona virus After the arrival of 268 new cases of infection, the number of people infected so far in the country has increased to 4,46,77,915, while the number of patients undergoing treatment has increased to 3 thousand 552.

Read this also- India’s preparation for China’s BF.7 variant, which did not spread in the country, isolated all samples



Source link

Related posts

Leave a Reply